Mumbai: The Indian listed subsidiary of British drug maker GlaxoSmithKline Plc, GlaxoSmithKline Pharmaceuticals Ltd (GSK Ltd), posted 7.63% growth in net profit at Rs141.08 crore during July-September quarter, as against the net profit of Rs131.97 crore in the year-ago quarter. The company’s sales during the period grew 12% at Rs522.68 crore compared with Rs478.84 crore.
The company, in a statement to stock exchanges, said the growth in total sales was impacted due to lower selling prices as a result of excise duty reduction being passed on to the customer.